VT News
Nick Luchey

Nick Luchey

Ask VT AI
View News Summary
  • Novartis nears $12B acquisition of Avidity Biosciences, a biotech with a promising platform for delivering RNA therapeutics to muscle tissue.
  • Milei's party projected to maintain veto power in Argentina's midterm elections, with gains in both chambers of Congress.
  • Controversial Israeli bills aim to halt Netanyahu's trial and block Bennett's election bid, sparking concerns over democracy and rule of law.
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Latest News
Ask VT AI
View News Summary
  • Novartis nears $12B acquisition of Avidity Biosciences, a biotech with a promising platform for delivering RNA therapeutics to muscle tissue.
  • Milei's party projected to maintain veto power in Argentina's midterm elections, with gains in both chambers of Congress.
  • Controversial Israeli bills aim to halt Netanyahu's trial and block Bennett's election bid, sparking concerns over democracy and rule of law.
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Most Reported By
News from Nick Luchey

Top Topics

Trending in U.S.

World

Sport